IGHE and asthma: Approximately 50–80% of patients with asthma present with a T2-high endotype, which may be allergic (IgE-mediated) or eosinophilic (IL-5-mediated), and is driven by cytokines such as interleukin-4 (IL-4), IL-5, and IL-13 [3].